A JACS study found that screening cancer incidence rates decreased during the COVID-19 pandemic, suggesting many "missed" cancer diagnoses. This will lead to upstaging at diagnosis, delayed treatment, and worse outcomes.
Read the full article at:
journals.lww.com/journalacs/β¦